Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $126.93 USD
Change Today +0.55 / 0.44%
Volume 1.1M
LH On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by LABORATORY CRP OF AMER HLDGS (LH) in the last 6 months

Announced 02/8/15
Altegrity, Inc.
Bankruptcy

Altegrity, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on February 8, 2015. The affiliates include Albatross Holding Company, LLC, Albatross Marketing and Trading, LLC, Altegrity Acquisition Corp., Altegrity Holding Corp., Altegrity Risk International LLC, Altegrity Security Consulting, Inc., CVM Solutions, LLC, D, D & C, Inc., Engenium Corporation, FDC Acquisition, ...
Read More


LH's price was unchanged after the transaction was announced on 02/8/15.
Creditor / Lender
CFIG Ocean Co-Invest SPV, LLC
Commerce Center TN Tower, L.P.
Hewlett-Packard Company
Insight Direct USA, Inc.
Laboratory Corp. of America Holdings
Microsoft Corporation
Teachers Insurance & Annuity Association of America, Endowment Arm
Verizon Communications Inc.
VMware, Inc.
Wilmington Trust, National Association
Financial Advisor
Evercore Group L.L.C.
Legal Advisor
Debevoise & Plimpton LLP
Venable LLP
Womble Carlyle Sandridge & Rice PLLC
Young Conaway Stargatt & Taylor, LLP
 
Announced 12/5/14
Bode Technology Group, Inc
Merger/Acquisition

Laboratory Corp. of America Holdings (NYSE:LH) acquired Bode Technology Group, Inc. from SolutionPoint International, Inc. on December 5, 2014. As a result of the acquisition, Bode Technology will operate as a wholly-owned subsidiary of Laboratory Corp. of America Holdings. Oppenheimer & Co. Inc. acted as financial advisor to Bode Technology Group.


LH's price was unchanged after the transaction was announced on 12/5/14.
Investor / Buyer
Laboratory Corp. of America Holdings
Creditor / Lender
SolutionPoint International, Inc.
Financial Advisor
Oppenheimer & Co. Inc.
 
Announced 11/25/14
15.00M for Vivify Health Inc.
Private Placement

Vivify Health Inc. announce that it will receive $15 million in its series B round of funding on November 25, 2014. The transaction included participation from new investors Laboratory Corp. of America Holdings and Envision Healthcare Holdings, Inc. As part of the round, Laboratory Corp. of America will join the company's board of directors. On the same date, the company announced that it has closed the first tranche of the transaction.


LH's price was unchanged after the transaction was announced on 11/25/14.
Investor / Buyer
Envision Healthcare Holdings, Inc.
Laboratory Corp. of America Holdings
 
Announced 11/18/14
15.00M for Advanced Animal Diagnostics, Inc.
Private Placement

Advanced Animal Diagnostics, Inc. announced that it will receive $14,770,889 in a round of funding on November 18, 2014. The company will issue common stocks as securities in the transaction. The company will issue the securities pursuant to exemption provided under Regulation D. The round will include participation from 11 investors.


LH's price was unchanged after the transaction was announced on 11/18/14.
Investor / Buyer
Cultivian Sandbox Ventures, LP
Intersouth Partners
Kansas Bioscience Authority
Laboratory Corp. of America Holdings
Middleland Capital
Novartis Venture Funds
 
Announced 11/3/14
6.38B for Covance Inc.
Merger/Acquisition

Laboratory Corp. of America Holdings (NYSE:LH) entered into a definitive agreement to acquire Covance Inc. (NYSE:CVD) for $6 billion on November 2, 2014. Under the terms of agreement, Laboratory Corp. shall acquire all shares of Covance for $105.12 each. Covance common stock holders, restricted stock holders, restricted stock units, deferred stock units and option holders will receive $75.76 in cash and 0.2686 Laboratory Corp. shares for each Covance share they own. ...
Read More


LH's price was unchanged after the transaction was announced on 11/3/14.
Investor / Buyer
Laboratory Corp. of America Holdings
Financial Advisor
Goldman, Sachs & Co.
Legal Advisor
Covington & Burling LLP
Cravath, Swaine & Moore LLP
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $126.93 USD +0.55

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $73.32 USD +0.27
Hologic Inc $33.99 USD +0.56
PAREXEL International Corp $67.49 USD +0.27
Quest Diagnostics Inc $75.81 USD +0.60
Sonic Healthcare Ltd A$20.94 AUD +0.31
View Industry Companies
 

Industry Analysis

LH

Industry Average

Valuation LH Industry Range
Price/Earnings 21.5x
Price/Sales 1.8x
Price/Book 3.8x
Price/Cash Flow 21.7x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.